AMANDA WHITE: Open Payments
NPI 1013064203 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,779 in 125 payments from 19 companies in 2025. Trend: 2023 $1,277 · 2024 $2,334 · 2025 $2,779
Food & beverage: $2,530Education: $249
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $594 |
| ANI Pharmaceuticals, Inc. | 12 | $488 |
| GlaxoSmithKline, LLC. | 22 | $309 |
| Regeneron Healthcare Solutions, Inc. | 13 | $230 |
| GENZYME CORPORATION | 14 | $212 |
| Mallinckrodt Hospital Products Inc. | 6 | $195 |
| Verona Pharma, Inc. | 15 | $170 |
| Grifols USA, LLC | 3 | $112 |
| Insmed, Inc. | 5 | $90 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
Products named: DUPIXENT, PURIFIED CORTROPHIN GEL, BREZTRI, NUCALA, ACTHAR, TEZSPIRE, Ohtuvayre, Prolastin-C Liquid.
Industry payments across NJ — which companies pay providers there.
